tiprankstipranks
Lineage Cell Therapeutics, Inc. (LCTX)
NYSE MKT:LCTX
Holding LCTX?
Track your performance easily

Lineage Therap (LCTX) Ownership - Who Owns Lineage Therap?

1,876 Followers

Lineage Therap (LCTX) Ownership Overview

53.70%6.38%27.88%6.85%5.19%
53.70% Insiders
27.88% Other Institutional Investors
6.85% ETFs
5.19% Public Companies and
Individual Investors
The ownership structure of Lineage Therap (LCTX) stock is a mix of institutional, retail, and individual investors. Approximately 41.11% of the company’s stock is owned by Institutional Investors, 53.70% is owned by Insiders, and 5.19% is owned by Public Companies and Individual Investors.
The ownership structure of Lineage Therap (LCTX) stock is a mix of institutional, retail, and individual investors. Approximately 34.26% of the company’s stock is owned by Institutional Investors, 53.70% is owned by Insiders, and 6.85% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 26, 2024
xxxxxxxxxxxxx
$9000
Nov 26, 2024
xxxxxxxxxxxxx
$8850
Nov 25, 2024
xxxxxxxxxxxxx
$22400
Nov 22, 2024
Brian Culley
President & Ceo,director
xxxxxxxxxxxxx
$24000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$4079541
Sep 30, 2024
xxxxxxxxxxxxx
$4526989

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
83,420,138Insider37.85%46,548,437
34,093,007Insider15.47%19,023,898
8,048,632Institution3.65%4,491,137
7,231,398Institution3.28%4,035,120
5,754,507Institution2.61%3,211,015
5,002,198Institution2.27%2,791,226
4,507,781Institution2.05%2,515,342
1,717,469Institution0.78%958,348
1,620,489Institution0.74%904,233
894,040Institution0.41%498,874

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,231,398Institution3.28%4,035,120
1,717,469Institution0.78%958,348
1,620,489Institution0.74%904,233
894,040Institution0.41%498,874
745,591Institution0.34%416,040
742,100Institution0.34%414,092
416,223Institution0.19%232,252
128,266Institution0.06%71,572
123,123Institution0.06%68,703
93,589Institution0.04%52,223

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,416,552Institution2.00%3,671,480
2,814,846Institution1.28%2,339,981
4,076,492Institution1.85%2,274,683
1,336,322Institution0.61%745,668
673,371Institution0.31%559,773
137,322Institution0.06%480,902
341,693Institution0.16%190,665
135,985Institution0.06%113,044
82,117Institution0.04%41,223
16,688Institution<0.01%9,823

FAQ

Who Owns Lineage Cell Therapeutics, Inc. (LCTX)?
According to the latest TipRanks data, approximately 27.88% of the company's stock is held by institutional investors, 53.70% is held by insiders, and 5.19% is held by retail investors.
    What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 27.88% of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by institutional investors.
      What percentage of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 5.19% of Lineage Cell Therapeutics, Inc. (LCTX) stock is held by retail investors.
        Who owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX)?
        Broadwood Partners Lp owns the most shares of Lineage Cell Therapeutics, Inc. (LCTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis